COMUNICADO DE QLIKTECH INTERNATIONAL AB (2)

(Continuación)

"With the release of QlikView 7, QlikTech is extending its value proposition of powerful business analysis applications that are simple, cost-effective, quick to deploy, and easy to use," said Måns Hultman, CEO of QlikTech. "With this release, QlikView can support massive data sets with hundreds of millions of unaggregated records, and can be deployed to an entire organization in days."

About QlikTech

QlikTech is dedicated to simplifying analysis for everyone. QlikTech's game-changing QlikView application is dramatically easier to deploy and use, inspiring fervent user adoption by business professionals who require it to run their organizations. QlikTech's patented technology allows instant, in memory, manipulation of massive datasets on low cost hardware, allowing affordable widespread deployment of highly sophisticated analytic applications in days. QlikView's click driven, visually interactive interface allows users to discover unanticipated insights hidden in operational systems with virtually no end-user training. QlikView has over 90,000 users at 1,600 customers in over 43 countries. In addition to hundreds of small and midsized companies, QlikTech's customers include large corporations such as AstraZeneca, Pfizer, Top Flite, 3M, and The Campbell Soup Company. QlikTech is privately held and venture backed by Accel Partners, Jerusalem Venture Partners, and Industrifonden. Founded in Sweden, QlikTech has subsidiaries in the United States, United Kingdom, Germany, and Scandinavia, and over 100 partners across the world.

QlikTech is a trademark of QlikTech International AB. All other company names, products and services used herein are trademarks or registered trademarks of their respective owners.

Source: QlikTech International AB

Contact: For more information on QlikView, please call Pelle Rosell , QlikTech, +46-(0)46-286-27-33, prl@qliktech.com www.qliktech.com

(171369)